Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 8
2005 5
2006 11
2007 7
2008 4
2009 7
2010 4
2011 6
2012 3
2013 2
2014 1
2015 3
2016 3
2017 17
2018 4
2019 6
2020 5
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 31079469

97 results

Results by year

Filters applied: . Clear all
Page 1
Edaravone administration in pivotal clinical Study 19.
Genge A, Brooks B. Genge A, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):298-299. doi: 10.1080/21678421.2019.1582672. Epub 2019 May 13. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31079469 No abstract available.
Edaravone and its clinical development for amyotrophic lateral sclerosis.
Takei K, Watanabe K, Yuki S, Akimoto M, Sakata T, Palumbo J. Takei K, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):5-10. doi: 10.1080/21678421.2017.1353101. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28872907 Review.
Exploratory double-blind, parallel-group, placebo-controlled extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis.
WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 17 STUDY GROUP. WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 17 STUDY GROUP. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):20-31. doi: 10.1080/21678421.2017.1362000. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28872918 Clinical Trial.
Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis.
WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 19 STUDY GROUP. WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 19 STUDY GROUP. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):55-63. doi: 10.1080/21678421.2017.1364269. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28872920 Clinical Trial.
97 results